ANTI-FUNGAL API
Consistent
Purity
Global-Ready
Molecules
Advanced
Manufacturing
Scalable
Production
Partnership
Support
Clotrimazole API has been developed by ASANA Pharmaceutical as part of its antifungal and dermatology product line. Clotrimazole API, listed under CAS number 23593-75-1, is a widely used imidazole derivative that treats a variety of fungal infections including athlete’s foot, ringworm, and candidiasis through its inhibition of fungal cell membrane synthesis.
ASANA Pharmaceutical focuses on the development and manufacturing of high-purity antifungal APIs like Clotrimazole. With expertise in topical and systemic infection control, ASANA delivers globally compliant, GMP-grade actives to pharmaceutical partners across North America, Europe, and Asia, ensuring consistent performance and trusted quality.
ASANA Pharmaceutical partners with formulation scientists and dermatology specialists to support the development of effective antifungal therapies for topical and mucosal applications. Clotrimazole [CAS No. 23593-75-1] is a broad-spectrum antifungal API commonly used in the treatment of infections caused by dermatophytes and yeasts, including candidiasis, tinea, and ringworm. It plays a vital role in ASANA’s dermatology and gynecology API portfolio. As demand grows for high-quality antifungal treatments, ASANA is committed to delivering:
Clotrimazole API are available on public databases such as Wikipidia!